It’s not polypharmacy that caused your LDL to increase. It’s a known side effect with mTOR inhibitors.
SGLT2 inhibitors also have great, large, clinical trials, as well for outcomes some of which they discovered serendipitously.
It’s not it, there is a lot of people who are FOMO, have hubris, think magically, it’s a great story, just it might be false. It’s better to be humble about it’s potential than to expect too much, and besides, there are so many other great drugs.
Normal nut consumtion should reduce LDL, you should check apoB as you might have low apoB still, albeit rare.
@RapAdmin, @DeStrider started rapamycin, got diabetic 5 years later and hyperlidemic. If I became diabetic and hyperlipidemic after starting a longevity drug I’d want a refund especially if there is no outcome data in humans. Especially if I see no reason why I would become diabetic if I wasn’t on the drug.
Because of distribution of outcomes, there will be people who are responding in an unfavorably way to a powerful drug, it’s just how things are. But since so many get high lipids especially, for example, and the average person do not want to treat it…? Is Deepak Chopra going to take statins?
If I started taking a longevity drug, and my HBA1c increases a lot - I would stop taking it, I wouldn’t start taking SGLT2 inhibitors or metformin or whatever. And I think it’s the same for a lot of people. It wouldn’t be persuasive to me for someone to say to just take statins or metformin or whatever. (the former might be good for other reasons).
It would be more persuasive to me if I was told that XX% of people probably needs to take statins or whatever to counter side effects of rapamycin from the get go. Then I would know what to expect.
I don’t want, I see what clinical trials exist.
Maybe IGF-1 inhibitor don’t cause measurable bad side effects a few months / a year or longer, or some other lifespan drug. That’s more interesting?
Of course for someone the lipids might not increase and they have no other measurable side effects from rapamycin.